CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
Advanced imaging and AI will power the manufacture of any cancer at the push of a button.
In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament to the power of personalized medicine, target cancer's unique protein signatures, rallying the immune system for a precise and potent attack.
A pivotal study uncovers the molecular signatures of mammographic calcifications in hormone receptor-positive, HER2-negative breast cancer.
In a notable advancement for Hodgkin's lymphoma (HL), recent research has introduced sophisticated therapeutic strategies designed to significantly boost patient outcomes.
Explore how scientists at St. Jude Children’s Research Hospital have identified causes for age-related differences in treatment outcomes of B-cell acute lymphoblastic leukemia.
At ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago, more than 300 experts will present cutting-edge research and technology that will shape the future of laboratory medicine and improve patient care.
A new study identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients.
Antidepressants may reduce the risk of relapse in people with alcohol use disorder—but only if the antidepressants are effective in reducing their depression symptoms. People whose depression symptoms do not improve with antidepressant treatment may have an increased risk for relapse into problem alcohol use.
While chemotherapy has advanced in personalization, personalized radiation therapy for cancer remains underdeveloped. A new project will use AI, in particular, deep reinforcement learning, to analyze multimodal data, and enhance cancer characterization and treatment to ultimately improve patient outcomes. Using personal health data, genetic information about the tumor, and patient treatment and follow-up data, digital twins will simulate diagnoses and treatment options to help physicians choose the most effective treatments and monitor responses over time.
20231127105913.jpg&width=400&height=400){kind=logo}
The inaugural reporting guidelines for precision medicine research, of which Wits University Professor Michèle Ramsay is co-author, have been published in Nature Medicine.
Medical products such as ointments or syringes reach their limits when it comes to delivering medication locally – and above all in a controlled manner over a longer period of time. Empa researchers are therefore developing polymer fibers that can deliver active ingredients precisely over the long term. These "liquid core fibers" contain drugs inside and can be processed into medical textiles.
Na Mayo Clinic, a missão de resolver o que está sem solução está no cerne de todos os casos de doenças raras. Cada diagnóstico é uma prova de perseverança, de inovação e da busca incessante por respostas. Este compromisso levou os pesquisadores do Centro de Medicina Personalizada da Mayo Clinic a desenvolver um sistema semiautomático, conhecido como RENEW, para reanalisar rapidamente casos de doenças raras não solucionadas.
En Mayo Clinic, la misión de resolver lo que está sin solución está en el centro de todos los casos de enfermedades raras. Cada diagnóstico es una prueba de perseverancia, innovación y búsqueda incesante de respuestas. Este compromiso llevó a los investigadores del Centro para Medicina Personalizada en Mayo Clinic desarrollar un sistema semiautomático, conocido como RENEW, para volver a analizar rápidamente los casos de enfermedades raras no resueltas.
Researchers used a machine learning model to predict personalized oxygenation targets. Data analysis revealed that mortality rates were lower for patients who received the oxygen level predicted to be most beneficial for them.
ASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings and innovations that could revolutionize cancer treatment.
Imagine um futuro em que os cuidados com a saúde sejam adaptados especificamente para você, até mesmo para as moléculas no interior das suas células. Tratamentos direcionados e estratégias preventivas são personalizados para o seu genoma. Seu mapa médico pessoal descreve variantes genéticas hereditárias, fornece orientação sobre riscos ambientais e oferece estratégias para manter a saúde do seu coração e prevenir o câncer, tornando-o tão único quanto o seu DNA.
Imagine un futuro en el que la atención a la salud se adapte específicamente a usted, incluso a las moléculas dentro de sus células. Los tratamientos específicos y las estrategias preventivas se adaptan a su genoma. Su mapa médico personal describe las variantes genéticas hereditarias, le brinda con orientación sobre los riesgos ambientales y ofrece estrategias para mantener la salud de su corazón y prevenir el cáncer, haciéndolo tan único como su ADN.
Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
Finding treatments for children with rare diseases has been a significant hurdle in the medical world. An unexpected source, the common fruit fly, is turning up answers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right